Central nervous system lymphoma and radiofrequency radiation – a case report and incidence data in the Swedish Cancer Register

The journal Medical Hypotheses has published online Central nervous system lymphoma and radiofrequency radiation – a case report and incidence data in the Swedish Cancer Register on non-Hodgkin lymphoma by Lennart Hardell, Michael Carlberg, Tarmo Koppel, Marie Nordström and  Lena K Hedendahl. The study presents a case study of a 53 year old woman with a tumor located in the  region of the brain more exposed to radiofrequency from a wireless phone. The authors review  the animal and human research linking lymphoma and nervous system cancers to wireless radiofrequency  radiation. The authors conclude that the increasing incidence of primary central nervous system lymphoma  may be caused by exposure to RF fields.

Abstract: Earlier animal studies have provided evidence that non-Hodgkin lymphoma (NHL) may be caused by exposure to radiofrequency (RF) radiation. This was recently confirmed by the U.S. National Toxicology (NTP) study that showed an increased incidence of malignant lymphoma in female mice exposed to the GSM modulated or the CDMA modulated cell phone RF radiation. Primary central nervous system lymphoma (PCNSL) is a rare malignancy in humans with poor prognosis. An increasing incidence has been reported in recent years. Based on a case-report we present the hypothesis that use of the hand-held mobile phone may be a risk factor for PCNSL. The increasing incidence of non-Hodgkin lymphoma in Sweden is discussed in relation to etiologic factors.

Lennart Hardell, Michael Carlberg, Tarmo Koppel, Marie Nordström, Lena K Hedendahl, Central nervous system lymphoma and radiofrequency radiation – a case report and incidence data in the Swedish Cancer Register on non-Hodgkin lymphoma, Medical Hypotheses, 2020, https://doi.org/10.1016/j.mehy.2020.110052.

https://ehtrust.org/central-nervous-system-lymphoma-and-radiofrequency-radiation-a-case-report-and-incidence-data-in-the-swedish-cancer-register-on-non-hodgkin-lymphoma/Source